A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Clinical trial NCT03085095 · COMPLETED
Trial details
- NCT number
- NCT03085095
- Sponsor
- Myovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2019-10-25
- Enrollment
- 1134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.